Compare AST SpaceMobile Inc (ASTS) vs Danaher Corporation (DHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AST SpaceMobile Inc vs Danaher Corporation — how do they compare? AST SpaceMobile Inc trades at $69.87 (market cap $21.90B), while Danaher Corporation trades at $198.99 (market cap $140.88B). The key difference: Danaher Corporation is far larger — about 6.4× AST SpaceMobile Inc's market cap, and Danaher Corporation pays a 0.8% dividend while AST SpaceMobile Inc pays none. Which is the better fit depends on your goals.
| ASTS | DHR | |
|---|---|---|
Market Cap | $21.90B | $140.88B |
Sector | Media | Health |
52-Week High | $133.09 | $242.05 |
52-Week Low | $36.91 | $161.91 |
Enterprise Value | $21.87B | $153.66B |
Dividend Yield | — | 0.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ASTS trades at $73.32, down 0.76% on the day, with a bearish technical signal from moving averages and mixed oscillators. The company reported revenue of $70.92 million in 2025 but sustained a net loss of $341.94 million, missing earnings expectations for three consecutive quarters. Recent news highlights potential in defense communications via satellite technology, though competition with SpaceX remains a focal point.
The outlook is speculative with high execution risk; analyst consensus is divided with a $90.33 price target. Investment opportunity hinges on successful satellite deployment and partnership execution, but persistent losses and intense competition pose significant downside risks for shareholders.
Danaher (DHR) trades at $199.05, up 1.57% on the day, with a bullish technical signal and strong analyst support. The stock has beaten earnings estimates for three consecutive quarters, though revenue growth remains modest and profit margins have compressed from pandemic peaks. Recent business developments include the shareholder approval of the Masimo acquisition and new product launches in its SCIEX division, suggesting ongoing strategic investment.
The outlook is cautiously optimistic, supported by a dominant 'Buy' analyst consensus and a price target implying ~7% upside. Key opportunities lie in the firm's biotechnology segment strength and strategic M&A. Risks include ongoing margin pressure, integration challenges from acquisitions, and a relatively high valuation (P/E of 38.6) that demands sustained earnings growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AST SpaceMobile Inc
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Read more on ASTS →About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →
